Financial Performance - The group's revenue for the six months ended September 30, 2025, was approximately HKD 24,700,000, an increase from HKD 20,300,000 for the same period in 2024, representing a growth of about 21.8%[4] - The loss attributable to the owners of the company for the six months ended September 30, 2025, was approximately HKD 500,000, significantly reduced from a loss of HKD 11,400,000 for the same period in 2024[4] - Gross profit for the six months ended September 30, 2025, was HKD 12,845,000, compared to HKD 9,901,000 for the same period in 2024, indicating a gross margin improvement[5] - Operating loss for the six months ended September 30, 2025, was HKD 426,000, a significant improvement from an operating loss of HKD 11,585,000 in the prior year[5] - The basic and diluted loss per share for the six months ended September 30, 2025, was HKD 1.48, compared to HKD 2.20 for the same period in 2024, showing a reduction in loss per share[6] - The net loss before tax for the six months ended September 30, 2025, was HKD 557,000, a substantial improvement compared to a net loss of HKD 11,679,000 for the same period in 2024[20] Dividend and Shareholder Information - The board of directors does not recommend the payment of an interim dividend for the six months ended September 30, 2025, consistent with the previous year where no dividend was declared[4] - The company did not recommend the payment of an interim dividend for the six months ended September 30, 2025[23] - As of September 30, 2025, major shareholders hold approximately 3,952,500 shares, representing 12.70% of the company's issued share capital[57] Assets and Liabilities - Total assets as of September 30, 2025, were HKD 33,713,000, an increase from HKD 28,989,000 as of March 31, 2025[7] - Current liabilities increased to HKD 17,198,000 as of September 30, 2025, compared to HKD 11,290,000 as of March 31, 2025, reflecting a rise in trade payables and contract liabilities[8] - The company's net assets as of September 30, 2025, were HKD 28,178,000, slightly down from HKD 28,735,000 as of March 31, 2025[8] - As of September 30, 2025, the net amount of loans and advances to customers was HKD 18,208,000, down from HKD 23,447,000 as of March 31, 2025[28] - The company reported a decrease in the provision for impairment of loans and advances to customers, from HKD 89,572,000 as of March 31, 2025, to HKD 80,798,000 as of September 30, 2025[28] Cash Flow and Liquidity - Cash and cash equivalents as of September 30, 2025, were HKD 10,343,000, up from HKD 3,964,000 as of March 31, 2025, indicating improved liquidity[8] - The net cash generated from operating activities for the six months ended September 30, 2025, was HKD 10,506,000, compared to HKD 1,393,000 for the same period in 2024, representing a significant increase[10] - The company reported a total cash and cash equivalents balance of HKD 10,343,000 at the end of the period, up from HKD 5,655,000 at the end of the previous year, reflecting a growth of 83.5%[10] - As of September 30, 2025, the group's cash and cash equivalents were approximately HKD 10,300,000, up from HKD 4,000,000 as of March 31, 2025[50] Revenue Segmentation - Total revenue from customer contracts for the six months ended September 30, 2025, was HKD 24,691,000, up from HKD 20,323,000 in 2024, indicating a growth of approximately 21.7%[15] - The retail and wholesale business segment generated revenue of HKD 20,246,000 for the six months ended September 30, 2025, compared to HKD 13,351,000 in 2024, marking an increase of 51.7%[17] - The lending business generated revenue of approximately HKD 4,400,000 during the six-month period, with expectations for sustainable income in the future[45] - The retail segment's revenue was approximately HKD 20,200,000 for the six months ended September 30, 2025, compared to HKD 13,400,000 in the same period last year, reflecting an increase of about 52%[47] Expenses and Costs - The company incurred employee benefit expenses of HKD 7,570,000 for the six months ended September 30, 2025, compared to HKD 6,855,000 in 2024, which is an increase of 10.4%[20] - The total financing costs for the six months ended September 30, 2025, were HKD 131,000, compared to HKD 94,000 in 2024, indicating an increase of 39.4%[20] Corporate Governance - The company has established an audit committee responsible for reviewing the annual report and financial statements, ensuring compliance with applicable accounting standards[61] - The audit committee has reviewed the unaudited consolidated results for the six-month period, confirming that the results were prepared in accordance with applicable accounting standards[62] - The company has complied with the corporate governance code as per GEM Listing Rules during the six-month period[60] - The remuneration committee is responsible for reviewing and setting the remuneration policies for directors and senior management based on the group's performance[63] - The nomination committee has been established to review and provide recommendations on any proposed changes to the board[64] - The company has adopted trading standards as per GEM Listing Rules, ensuring compliance by all directors during the six-month period[65] - The board of directors includes both executive and independent non-executive members, ensuring a balanced governance structure[66] Business Strategy and Operations - The group plans to continue improving its existing business and explore new investments to broaden its business scope and maximize shareholder returns[48] - The group operates several retail stores and focuses on offering a diverse range of products, including health products and ready-to-eat meals[46] - The group has obtained distribution and sales rights for health supplement products from FromBio Co. Limited, a global healthcare company established in 2006 in South Korea[42] - The group has not engaged in any significant investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures during the reporting period[53] - During the six-month period, the group did not purchase, sell, or redeem any listed securities[58] - The company has not granted any share options under the share option scheme as of September 30, 2025[31] - There were no guarantees provided to third parties as of September 30, 2025[32]
仍志集团控股(08079) - 2026 - 中期财报